{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:58:20Z","timestamp":1784231900387,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S04516N"],"award-info":[{"award-number":["1S04516N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104901","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T21:36:20Z","timestamp":1596576980000},"page":"104901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Viral fitness of MHV-68 viruses harboring drug resistance mutations in the protein kinase or thymidine kinase"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-9776","authenticated-orcid":false,"given":"Erika","family":"Trompet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Topalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104901_bib1","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.02568-12","article-title":"Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness","volume":"57","author":"Abram","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib2","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1128\/AAC.00040-15","article-title":"Reduced viral fitness and lack of cross-class resistance with integrase strand transfer inhibitor and nucleoside reverse transcriptase inhibitor resistance mutations","volume":"59","author":"Andreatta","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fmicb.2017.00613","article-title":"Reactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus: an update","volume":"8","author":"Aneja","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104901_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0026-895X(25)14193-X","article-title":"Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene","volume":"28","author":"Balzarini","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104901_bib5","first-page":"1077","article-title":"Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds","volume":"6","author":"Balzarini","year":"1986","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2020.104901_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0026-895X(25)13017-4","article-title":"Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene","volume":"32","author":"Balzarini","year":"1987","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104901_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4149\/av_2019_411","article-title":"Recombinant luciferase-expressing murine gammaherpesvirus 68 as a tool for rapid antiviral screening","volume":"63","author":"Briestenska","year":"2019","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib8","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1128\/JVI.02473-14","article-title":"Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium","volume":"89","author":"Burnham","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib9","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1128\/JVI.73.6.4786-4793.1999","article-title":"Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir","volume":"73","author":"Cannon","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib10","first-page":"289","article-title":"The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma","volume":"312","author":"Casper","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2020.104901_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","article-title":"Gammaherpesviruses and lymphoproliferative disorders","volume":"9","author":"Cesarman","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.antiviral.2020.104901_bib12","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1128\/JVI.01058-12","article-title":"Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins","volume":"86","author":"Chang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib13","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1128\/JVI.02880-14","article-title":"BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins","volume":"89","author":"Chang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib14","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1128\/AAC.00259-10","article-title":"Differentiation between polymorphisms and resistance-associated mutations in human cytomegalovirus DNA polymerase","volume":"54","author":"Chevillotte","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib15","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.00511-13","article-title":"Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance","volume":"57","author":"Chou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib16","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/JVI.03338-12","article-title":"Activity and mechanism of action of HDVD, a novel pyrimidine nucleoside derivative with high levels of selectivity and potency against gammaherpesviruses","volume":"87","author":"Coen","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib17","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.1128\/JVI.02231-13","article-title":"Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells","volume":"87","author":"Coen","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib18","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1128\/AAC.03957-14","article-title":"Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses","volume":"58","author":"Coen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib19","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.3390\/v6114731","article-title":"KSHV targeted therapy: an update on inhibitors of viral lytic replication","volume":"6","author":"Coen","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104901_bib20","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1128\/AAC.02825-14","article-title":"Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases","volume":"58","author":"Coen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib21","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/JVI.77.4.2410-2417.2003","article-title":"Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency","volume":"77","author":"Coleman","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JVI.78.2.603-611.2004","article-title":"Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants","volume":"78","author":"Collins","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib23","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0002-9343(92)90329-A","article-title":"Mechanism of action of foscarnet against viral polymerases","volume":"92","author":"Crumpacker","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2020.104901_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00838054","article-title":"The antiviral prophylaxis of post-transplant lymphoproliferative disorder","volume":"20","author":"Davis","year":"1998","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.antiviral.2020.104901_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrmicro975","article-title":"Antivirals and antiviral strategies","volume":"2","author":"De Clercq","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104901_bib26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2020.104901_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2010.02.001","article-title":"Human and viral nucleoside\/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties","volume":"86","author":"Deville-Bonne","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104901_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-981-10-5765-6_14","article-title":"Murine gammaherpesvirus 68: a small animal model for gammaherpesvirus-associated diseases","volume":"1018","author":"Dong","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2020.104901_bib29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/IDR.S180908","article-title":"Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review","volume":"12","author":"El Helou","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.antiviral.2020.104901_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fonc.2018.00265","article-title":"Epstein-barr virus-associated malignancies: roles of viral oncoproteins in carcinogenesis","volume":"8","author":"El-Sharkawy","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.antiviral.2020.104901_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.pathol.1.110304.100133","article-title":"KSHV infection and the pathogenesis of Kaposi's sarcoma","volume":"1","author":"Ganem","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.antiviral.2020.104901_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-800098-4.00002-7","article-title":"KSHV: pathways to tumorigenesis and persistent infection","volume":"88","author":"Giffin","year":"2014","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2020.104901_bib33","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1128\/JVI.79.23.14647-14659.2005","article-title":"Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion","volume":"79","author":"Gill","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib34","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1128\/JVI.00147-07","article-title":"Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles","volume":"81","author":"Gill","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib35","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1128\/AAC.42.11.2923","article-title":"The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase","volume":"42","author":"Gustafson","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib36","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1128\/JVI.00695-14","article-title":"Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors","volume":"88","author":"Hu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fonc.2017.00229","article-title":"Targeting nucleotide biosynthesis: a strategy for improving the oncolytic potential of DNA viruses","volume":"7","author":"Irwin","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.antiviral.2020.104901_bib38","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Reactivation and lytic replication of EBV","author":"Kenney","year":"2007"},{"key":"10.1016\/j.antiviral.2020.104901_bib39","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1128\/JVI.00001-07","article-title":"The ORF49 protein of murine gammaherpesvirus 68 cooperates with RTA in regulating virus replication","volume":"81","author":"Lee","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib40","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1128\/JVI.00120-07","article-title":"Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II","volume":"81","author":"Lee","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib41","doi-asserted-by":"crossref","first-page":"11913","DOI":"10.1128\/JVI.01100-08","article-title":"Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production","volume":"82","author":"Lee","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib42","doi-asserted-by":"crossref","first-page":"11557","DOI":"10.1128\/JVI.74.24.11557-11565.2000","article-title":"Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts","volume":"74","author":"Lembo","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib43","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMoa1714656","article-title":"Maribavir for preemptive treatment of cytomegalovirus reactivation","volume":"381","author":"Maertens","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104901_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1053-2498(01)00407-7","article-title":"Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients","volume":"21","author":"Malouf","year":"2002","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.antiviral.2020.104901_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3851\/IMP1565","article-title":"Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity","volume":"15","author":"Martin","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2020.104901_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2018.07.020","article-title":"Comparison of antiviral resistance across acute and chronic viral infections","volume":"158","author":"Mason","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104901_bib47","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/JVI.02487-09","article-title":"The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production","volume":"84","author":"Meng","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib48","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1099\/vir.0.031542-0","article-title":"In vivo function of the murid herpesvirus-4 ribonucleotide reductase small subunit","volume":"92","author":"Milho","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2009.04.007","article-title":"Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase","volume":"389","author":"Murata","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104901_bib50","doi-asserted-by":"crossref","first-page":"21557","DOI":"10.1074\/jbc.M109.015685","article-title":"Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein","volume":"284","author":"Nakayama","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104901_bib51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12981-015-0066-7","article-title":"Defining the fitness of HIV-1 isolates with dual\/mixed co-receptor usage","volume":"12","author":"Nankya","year":"2015","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.antiviral.2020.104901_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1098\/rstb.2000.0779","article-title":"Natural history of murine gamma-herpesvirus infection","volume":"356","author":"Nash","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.antiviral.2020.104901_bib53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AAC.42.1.170","article-title":"In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents","volume":"42","author":"Neyts","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-540-79086-0_11","article-title":"Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases","author":"Nijhuis","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104901_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060167","article-title":"Clinical importance of Epstein(-)Barr virus-associated gastric cancer","volume":"10","author":"Nishikawa","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.antiviral.2020.104901_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/infdis\/jit437","article-title":"Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient","volume":"209","author":"Pan","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104901_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159847","article-title":"Competitive fitness of influenza B viruses possessing E119A and H274Y neuraminidase inhibitor resistance-associated substitutions in ferrets","volume":"11","author":"Pascua","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104901_bib58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104901_bib59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/rmv.615","article-title":"Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir","volume":"19","author":"Prichard","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00238-19","article-title":"Mechanisms of B-cell oncogenesis induced by epstein-barr virus","volume":"93","author":"Saha","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13238-013-0005-0","article-title":"Murine gammaherpesvirus-68 ORF38 encodes a tegument protein and is packaged into virions during secondary envelopment","volume":"5","author":"Shen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2020.104901_bib62","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1128\/JVI.00079-15","article-title":"Gammaherpesvirus tegument protein ORF33 is associated with intranuclear capsids at an early stage of the tegumentation process","volume":"89","author":"Shen","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib63","doi-asserted-by":"crossref","first-page":"14120","DOI":"10.1073\/pnas.1312901110","article-title":"Deoxynucleoside triphosphate (dNTP) synthesis and destruction regulate the replication of both cell and virus genomes","volume":"110","author":"Stillman","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104901_bib64","first-page":"413","article-title":"Antiviral drug resistance: mechanisms and clinical implications","volume":"24","author":"Strasfeld","year":"2010","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.antiviral.2020.104901_bib65","first-page":"9530","article-title":"Distribution and effects of amino acid changes in drug-resistant alpha and beta herpesviruses DNA polymerase","volume":"44","author":"Topalis","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104901_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.01.003","article-title":"Thymidine kinase and protein kinase in drug-resistant herpesviruses: heads of a Lernaean Hydra","volume":"37","author":"Topalis","year":"2018","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.antiviral.2020.104901_bib67","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1128\/JVI.00286-12","article-title":"Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures","volume":"86","author":"Tsibris","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib68","first-page":"291","article-title":"Letermovir treatment of human cytomegalovirus infection antiinfective agent","volume":"38","author":"Verghese","year":"2013","journal-title":"Drugs Future"},{"key":"10.1016\/j.antiviral.2020.104901_bib69","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1128\/JVI.03110-13","article-title":"Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA","volume":"88","author":"Wakeman","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104901_bib70","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1086\/368385","article-title":"Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis","volume":"187","author":"Weinberg","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104901_bib71","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1515\/hsz-2017-0101","article-title":"Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus","volume":"398","author":"Wong","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104901_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007135","article-title":"Comparative fitness of West Nile virus isolated during California epidemics","volume":"13","author":"Worwa","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104901_bib73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1042\/bj20031832","article-title":"Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase","volume":"379","author":"Wu","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2020.104901_bib74","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1021\/bi0484872","article-title":"Characterization of three essential residues in the conserved ATP-binding region of Epstein-Barr virus thymidine kinase","volume":"44","author":"Wu","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104901_bib75","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fmicb.2019.00941","article-title":"Alpha-herpesvirus thymidine kinase genes mediate viral virulence and are potential therapeutic targets","volume":"10","author":"Xie","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104901_bib76","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein-Barr virus and oncogenesis: from latent genes to tumours","volume":"22","author":"Young","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2020.104901_bib77","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.antiviral.2020.104901_bib78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.celrep.2019.04.020","article-title":"Conserved herpesvirus protein kinases target SAMHD1 to facilitate virus replication","volume":"28","author":"Zhang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2020.104901_bib79","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1128\/JVI.02378-08","article-title":"Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4","volume":"83","author":"Zhu","year":"2009","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:13Z","timestamp":1759062793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":79,"alternative-id":["S0166354220303156"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104901","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral fitness of MHV-68 viruses harboring drug resistance mutations in the protein kinase or thymidine kinase","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104901"}}